Lenacapavir is already sold under the commercial name Sunlenca for the treatment of HIV infection in the US, Canada, Europe, and Israel. In Israel, Lenacapavir is currently available only to ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...